Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1321-01

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Recall #: D-432-2013
Affected scope: 4,440 Bottles
Initiated: April 1, 2013

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Drug →

View my saved recalls

Lloyd Inc. of Iowa recalled Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle,… - a moderate-severity action.

Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle,… was recalled by Lloyd Inc. of Iowa in May 29, 2013. Reason: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to d…. Check the official notice for the remedy. Verify recall #D-432-2013 with the FDA Drug before acting.

The recall

Lloyd Inc. of Iowa issued this moderate-severity FDA Drug recall-cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to d….

Moderate
severity level: Class II
classification: May 29, 2013
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-432-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Levothroid (levothyroxine sodium tablets, USP) , 50 mcg, RX only, 100 tablets per bottle, Manufactured for Forest Pharmaceuticals, Inc, St. Louis, MO by Lloyd Pharmaceutical, Shenandoah, IA, NDC 0456-1321-01

Reason for recall

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Terminated
Recall number	D-432-2013
Date reported	May 29, 2013
Date initiated	April 1, 2013
Recalling firm	Lloyd Inc. of Iowa
Firm location	Shenandoah, IA
Affected scope	4,440 Bottles
Distribution	The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-432-2013) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on May 29, 2013. Severity: Moderate. Recall number: D-432-2013.

Where was the recalled product distributed? ▼

Distribution: The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

H&M Reannounces Recall of Children's Wate… 2013-05-29 Vive La Fete Recalls Children's Pajamas D… 2013-05-29 KTM North America Recalls KTM and Husaber… 2013-05-29 Pottery Barn Kids Recalls Sweet Lambie Cr… 2013-05-29

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Rite Aid brand Maximum Strength Tussin Co… 2013-05-29 Levoxyl (levothyroxine sodium) tablets, U… 2013-05-29 Levoxyl (levothyroxine sodium) tablets, U… 2013-05-29 Levoxyl (levothyroxine sodium) tablets, U… 2013-05-29

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported May 29, 2013. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026